A randomized controlled study to assess the effect of â??Shirodharaâ?? as an add-on therapy on the post Covid common mental disorders (Depression and Anxiety) in Covid-19 survivors.

ALL INDIA INSTITUTE OF AYRVEDA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年2月6日

试验速览

暂无简介。

•1.Aged between 18 to 60 years
•2.Having developed COVID positive status
•3.Diagnosed as having major depressive and generalized anxiety disorder by a psychiatrist (co-supervisor) as per diagnostic criteria listed in DSM-5
•4. Currently receiving treatment (Fluoxetine and or Clonazepam) and planning to pursue follow up psychiatry care for next 1 month at study center.
•5.Able to understand Hindi/English
•6.Medically stable to participate in Shirdohara intervention as assessed by treating psychiatrist on medical examination.

•1.Past history of psychiatric illness prior to developing COVID .
•2.Reporting presence of suicidal thoughts/ideation or attempts within last 2 weeks.
•3.Already on any alternative form of therapy besides standard pharmacotherapy and or psychotherapy for depression
•4.Having history suggestive of being diagnosed any medical condition requiring hospitalization currently or in recent past 6 weeks making participation in Shirodhara based program difficult
•5.The patient having symptoms like cough, sneezing, running nose currently making participation in Shirodhara based program difficult
•6.Pregnant and lactating women

发起方

ALL INDIA INSTITUTE OF AYRVEDA